RhumbLine Advisers
SPPI

RhumbLine Advisers’s Spectrum Pharmaceuticals Inc SPPI Stock Holding History

RhumbLine Advisers’s Portfolio SPPI Stock Details SPPI Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q3 		– Sell
-3,600
Closed -$3.46K – 4420
2023
Q2 		$3.46K Buy
+3,600
New +$3.56K ﹤0.01% 4141
2022
Q2 		– Sell
-162,991
Closed -$210K – 3299
2022
Q1 		$210K Sell
162,991
-251,806
-61% -$232K ﹤0.01% 2744
2021
Q4 		$527K Buy
414,797
+10,259
+3% +$18.3K ﹤0.01% 2488
2021
Q3 		$882K Sell
404,538
-46,012
-10% -$126K ﹤0.01% 2283
2021
Q2 		$1.69M Sell
450,550
-53,369
-11% -$185K ﹤0.01% 2023
2021
Q1 		$1.64M Buy
503,919
+11,440
+2% +$41K ﹤0.01% 1991
2020
Q4 		$1.68M Buy
492,479
+65,256
+15% +$269K ﹤0.01% 1929
2020
Q3 		$1.74M Buy
427,223
+41,244
+11% +$157K ﹤0.01% 1752
2020
Q2 		$1.3M Buy
385,979
+7,960
+2% +$23.2K ﹤0.01% 1933
2020
Q1 		$881K Buy
378,019
+18,338
+5% +$50.2K ﹤0.01% 1934
2019
Q4 		$1.31M Buy
359,681
+23,726
+7% +$192K ﹤0.01% 1969
2019
Q3 		$2.79M Buy
335,955
+18,264
+6% +$148K 0.01% 1552
2019
Q2 		$2.73M Buy
317,691
+22,095
+7% +$198K 0.01% 1547
2019
Q1 		$3.16M Buy
295,596
+5,871
+2% +$62.9K 0.01% 1442
2018
Q4 		$2.54M Buy
289,725
+56,471
+24% +$719K 0.01% 1507
2018
Q3 		$3.92M Buy
233,254
+2,370
+1% +$51.3K 0.01% 1266
2018
Q2 		$4.84M Buy
230,884
+13,812
+6% +$256K 0.01% 1120
2018
Q1 		$3.49M Buy
217,072
+6,430
+3% +$127K 0.01% 1281
2017
Q4 		$3.99M Buy
210,642
+46,758
+29% +$847K 0.01% 1212
2017
Q3 		$2.31M Buy
163,884
+7,550
+5% +$68.3K 0.01% 1523
2017
Q2 		$1.17M Buy
156,334
+5,754
+4% +$37.6K ﹤0.01% 1866
2017
Q1 		$979K Buy
150,580
+40,984
+37% +$229K ﹤0.01% 1926
2016
Q4 		$486K Buy
109,596
+12
+0% +$50 ﹤0.01% 2244
2016
Q3 		$512K Buy
109,584
+12,455
+13% +$73.8K ﹤0.01% 2190
2016
Q2 		$638K Sell
97,129
-15,556
-14% -$110K ﹤0.01% 2043
2016
Q1 		$717K Buy
112,685
+7,930
+8% +$40.7K ﹤0.01% 1992
2015
Q4 		$632K Buy
104,755
+6,400
+7% +$36.6K ﹤0.01% 2097
2015
Q3 		$588K Buy
98,355
+5,710
+6% +$39.6K ﹤0.01% 2118
2015
Q2 		$634K Sell
92,645
-8,480
-8% -$53.8K ﹤0.01% 2174
2015
Q1 		$614K Buy
101,125
+6,550
+7% +$43.6K ﹤0.01% 2172
2014
Q4 		$655K Buy
94,575
+6,325
+7% +$46.5K ﹤0.01% 2090
2014
Q3 		$718K Buy
88,250
+500
+0.6% +$3.91K ﹤0.01% 1988
2014
Q2 		$713K Sell
87,750
-3,194
-4% -$24.2K ﹤0.01% 2050
2014
Q1 		$713K Sell
90,944
-2,620
-3% -$22.2K ﹤0.01% 2007
2013
Q4 		$828K Sell
93,564
-6,550
-7% -$58.5K ﹤0.01% 1944
2013
Q3 		$840K Buy
100,114
+1,345
+1% +$10.9K ﹤0.01% 1890
2013
Q2 		$737K Buy
+98,769
New +$758K ﹤0.01% 1969

RhumbLine Advisers's SPPI Position: Q3 2023 in Review

RhumbLine Advisers sold out of Spectrum Pharmaceuticals Inc (SPPI) in Q3 2023, closing a stake of 3,600 shares — an estimated $3.46K sold.

RhumbLine Advisers first reported a position in SPPI in Q2 2013 and held it in 37 quarters. The position peaked at $4.84M in Q2 2018. 0 funds tracked by Wall St. Rank hold SPPI as of Q3 2023.

  • RhumbLine Advisers reported no remaining Spectrum Pharmaceuticals Inc position as of Q3 2023 after selling out during the quarter.
  • RhumbLine Advisers sold 3,600 Spectrum Pharmaceuticals Inc shares in Q3 2023, an estimated $3.46K.
  • RhumbLine Advisers first reported a position in Spectrum Pharmaceuticals Inc in Q2 2013 and held it in 37 quarters.
  • RhumbLine Advisers's Spectrum Pharmaceuticals Inc position peaked at $4.84M in Q2 2018.
  • 0 funds tracked by Wall St. Rank held Spectrum Pharmaceuticals Inc as of Q3 2023.

Based on RhumbLine Advisers's 13F filing for Q3 2023, filed 9 Nov 2023.